Infinity Pharmaceuticals, Inc.Cambridge, MA United States
Company Description
Infinity Pharmaceuticals acts on the endless possibilities for new cancer treatments. The firm works to discover and develop targeted therapies for different types of cancer, inflammatory conditions, and pain. Such targeted therapies aim at inhibiting specific disease signaling pathways and proteins. Infinity Pharmaceuticals has several candidates in clinical trials, including some that are being investigated in combination with existing cancer treatments. Candidates include IPI-926 (also known as Hedgehog) to treat several types of cancer, as well as IPI-504, also for cancer, IPI-940 to treat inflammation and pain, and IPI-145 for cancer and inflammatory diseases.
| 780 Memorial Dr. | Phone: 617-453-1000 | http://www.ipi.com |
| Cambridge, MA 02139 | Fax: 617-453-1001 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Infinity Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
Executives
| 58 executives listed for Infinity Pharmaceuticals, Inc.'s Cambridge, MA location. | ||
| CEO and Director | Adelene Perkins | |
|---|---|---|
| Chief Medical Officer | Pedro Santabarbara | |
| President, Research and Development and Chief Scientific Officer | Julian Adams | |
Financials
| Company Type | Public - NASDAQ: INFI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 190 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Infinity Pharmaceuticals, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
